首页> 外文期刊>Circulation research: a journal of the American Heart Association >Calpastatin Counteracts Pathological Angiogenesis by Inhibiting Suppressor of Cytokine Signaling 3 Degradation in Vascular Endothelial Cells
【24h】

Calpastatin Counteracts Pathological Angiogenesis by Inhibiting Suppressor of Cytokine Signaling 3 Degradation in Vascular Endothelial Cells

机译:钙抑素通过抑制血管内皮细胞中细胞因子信号传导3降解的抑制剂来抵消病理性血管生成。

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale: Janus kinase/signal transducer and activator of transcription (JAK/STAT) signals and their endogenous inhibitor, suppressor of cytokine signaling 3 (SOCS3), in vascular endothelial cells (ECs) reportedly dominate the pathological angiogenesis. However, how these inflammatory signals are potentiated during pathological angiogenesis has not been fully elucidated. We suspected that an intracellular protease calpain, which composes the multifunctional proteolytic systems together with its endogenous inhibitor calpastatin (CAST), contributes to the JAK/STAT regulations.
机译:原理:据报道,血管内皮细胞(EC)中的Janus激酶/信号转导和转录激活剂(JAK / STAT)信号及其内源性抑制剂,细胞因子信号传导抑制因子3(SOCS3)占主导地位。然而,尚未完全阐明在病理性血管生成过程中如何增强这些炎症信号。我们怀疑胞内蛋白酶钙蛋白酶与多功能蛋白水解系统及其内源性抑制剂钙蛋白酶抑制素(CAST)一起构成了JAK / STAT法规。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号